Mingjie Li

Medicine & Life Sciences

1. Small Interfering RNA 100%
2. Catalytic RNA 78%
3. HIV-1 68%
4. Genetic Therapy 65%
5. HIV 50%
6. Genetic Recombination 42%
7. RNA 38%
8. Genes 37%
9. Transgenes 35%
10. Hematopoietic Stem Cells 32%
11. HIV Infections 31%
12. T-Lymphocytes 30%
13. Stem Cells 28%
14. B-Lymphocytes 26%
15. Macrophages 19%
16. RNA Interference 19%
17. DNA Damage 18%
18. Nervous System Diseases 18%
19. In Vitro Techniques 17%
20. SCID Mice 17%
21. PAX5 Transcription Factor 16%
22. Acquired Immunodeficiency Syndrome 15%
23. Saimiriine Herpesvirus 2 15%
24. AIDS-Related Lymphoma 15%
25. Central Nervous System 15%
26. Proteins 15%
27. Immunoglobulin Heavy Chains 15%
28. Recombinational DNA Repair 14%
29. nucleolin 14%
30. Calnexin 14%
31. Apolipoprotein E2 14%
32. Small Nuclear RNA 14%
33. Tars 13%
34. Calreticulin 13%
35. Gene Expression 12%
36. Severe Combined Immunodeficiency 12%
37. Dependovirus 11%
38. Transfection 11%
39. Plasmids 11%
40. Epstein-Barr Virus Infections 11%
41. Proteasome Inhibitors 11%
42. Cytosine 11%
43. Heterogeneous-Nuclear Ribonucleoprotein D 11%
44. Cell- and Tissue-Based Therapy 10%
45. Interferons 10%
46. Down-Regulation 10%
47. Neurosciences 10%
48. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10%
49. Ribosomal DNA 10%
50. Myeloid Cells 9%